Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Craniofacial granulomatous lesions].

C Brocheriou, A de Roquancourt, M F D'Agay

    Annales De Pathologie
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Cranio-facial granulomatous lesions present diverse histological types and etiologies, including infections and inflammatory conditions. Distinguishing lethal midline granuloma from other granulomas is crucial due to its distinct, aggressive presentation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.

    European journal of nuclear medicine and molecular imaging·2014
    Same author

    Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.

    British journal of cancer·2014
    Same author

    HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.

    British journal of cancer·2013
    Same author

    BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit.

    European radiology·2011
    Same author

    Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

    British journal of cancer·2011
    Same author

    [Sentinel node biopsy in breast cancer].

    Bulletin du cancer·2009

    Area of Science:

    • Pathology
    • Dermatology
    • Otolaryngology

    Background:

    • Granulomatous lesions in the cranio-facial area exhibit diverse histological features, including lymphohistiocytic, tuberculoid-like, and giant cell predominant patterns.
    • Etiologies are varied, encompassing foreign body reactions, sarcoidosis, leprosy, rhinoscleroma, fungal infections (zygomycosis, rhinosporidiosis), and parasitic diseases.

    Purpose of the Study:

    • To review the diverse nature and etiologies of cranio-facial granulomatous lesions.
    • To highlight the diagnostic considerations for lethal midline granuloma, differentiating it from malignant processes and Wegener's granulomatosis.
    • To contrast lethal midline granuloma with central giant cell granuloma and histiocytosis X.

    Main Methods:

    • Literature review and synthesis of existing knowledge on cranio-facial granulomatous lesions.

    Related Experiment Videos

  • Histopathological classification and etiological correlation of different granuloma types.
  • Clinical presentation and evolutionary patterns analysis.

    • Main Results:

    • Granulomatous lesions present varied histology: lymphohistiocytic, epithelioid/giant cell (tuberculoid-like), or predominantly giant cell.
    • Identified etiologies include infections (bacterial, fungal, parasitic), foreign bodies, sarcoidosis, and leprosy.
    • Lethal midline granuloma is a distinct clinical entity with necrotic, progressive destruction, requiring exclusion of malignancy and Wegener's granulomatosis for an "idiopathic midline non-healing granuloma" diagnosis.

    Conclusions:

    • Cranio-facial granulomatous lesions are histologically diverse and etiologically multifactorial.
    • Accurate diagnosis, particularly for lethal midline granuloma, is critical due to its potential for dissemination and aggressive course.
    • Distinguishing between different granuloma types, such as lethal midline granuloma, central giant cell granuloma, and histiocytosis X, is essential for appropriate management.